These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 20850454)

  • 1. Chemoenzymatic synthesis, inhibition studies, and X-ray crystallographic analysis of the phosphono analog of UDP-Galp as an inhibitor and mechanistic probe for UDP-galactopyranose mutase.
    Partha SK; Sadeghi-Khomami A; Slowski K; Kotake T; Thomas NR; Jakeman DL; Sanders DA
    J Mol Biol; 2010 Nov; 403(4):578-90. PubMed ID: 20850454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of substrate binding to UDP-galactopyranose mutase: crystal structures in the reduced and oxidized state complexed with UDP-galactopyranose and UDP.
    Partha SK; van Straaten KE; Sanders DA
    J Mol Biol; 2009 Dec; 394(5):864-77. PubMed ID: 19836401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical probes of UDP-galactopyranose mutase.
    Carlson EE; May JF; Kiessling LL
    Chem Biol; 2006 Aug; 13(8):825-37. PubMed ID: 16931332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-directed mutagenesis of UDP-galactopyranose mutase reveals a critical role for the active-site, conserved arginine residues.
    Chad JM; Sarathy KP; Gruber TD; Addala E; Kiessling LL; Sanders DA
    Biochemistry; 2007 Jun; 46(23):6723-32. PubMed ID: 17511471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing UDP-galactopyranose mutase binding pocket: a dramatic effect on substitution of the 6-position of UDP-galactofuranose.
    Eppe G; Peltier P; Daniellou R; Nugier-Chauvin C; Ferrières V; Vincent SP
    Bioorg Med Chem Lett; 2009 Feb; 19(3):814-6. PubMed ID: 19119008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent ligands for prokaryotic UDP-galactopyranose mutase that exploit an enzyme subsite.
    Dykhuizen EC; Kiessling LL
    Org Lett; 2009 Jan; 11(1):193-6. PubMed ID: 19067595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and inhibition properties of conformational probes for the mutase-catalyzed UDP-galactopyranose/furanose interconversion.
    Caravano A; Mengin-Lecreulx D; Brondello JM; Vincent SP; Sinaÿ P
    Chemistry; 2003 Dec; 9(23):5888-98. PubMed ID: 14673861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand binding and substrate discrimination by UDP-galactopyranose mutase.
    Gruber TD; Borrok MJ; Westler WM; Forest KT; Kiessling LL
    J Mol Biol; 2009 Aug; 391(2):327-40. PubMed ID: 19500588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the mechanism of binding of UDP-galactopyranose to UDP-galactopyranose mutase by STD-NMR spectroscopy and molecular modeling.
    Yuan Y; Wen X; Sanders DA; Pinto BM
    Biochemistry; 2005 Nov; 44(43):14080-9. PubMed ID: 16245924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of nonionic substrate mimics of UDP-Galp as candidate inhibitors of UDP galactopyranose mutase (UGM).
    Kuppala R; Borrelli S; Slowski K; Sanders DA; Ravindranathan Kartha KP; Pinto BM
    Bioorg Med Chem Lett; 2015 May; 25(9):1995-7. PubMed ID: 25819094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,4-Anhydrogalactopyranose is not an intermediate of the mutase catalyzed UDP-galactopyranose/furanose interconversion.
    Caravano A; Sinaÿ P; Vincent SP
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1123-5. PubMed ID: 16377186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of binding of UDP-Galf and UDP-[3-F]Galf to UDP-galactopyranose mutase by STD-NMR spectroscopy, molecular dynamics, and CORCEMA-ST calculations.
    Yuan Y; Bleile DW; Wen X; Sanders DA; Itoh K; Liu HW; Pinto BM
    J Am Chem Soc; 2008 Mar; 130(10):3157-68. PubMed ID: 18278916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Novel Inhibitors of UDP-Galactopyranose Mutase by Structure-Based Virtual Screening.
    Karunan Partha S; Sadeghi-Khomami A; Cren S; Robinson RI; Woodward S; Slowski K; Berast L; Zheng B; Thomas NR; Sanders DA
    Mol Inform; 2011 Oct; 30(10):873-83. PubMed ID: 27468107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis of ligand binding to UDP-galactopyranose mutase from Mycobacterium tuberculosis using substrate and tetrafluorinated substrate analogues.
    van Straaten KE; Kuttiyatveetil JR; Sevrain CM; Villaume SA; Jiménez-Barbero J; Linclau B; Vincent SP; Sanders DA
    J Am Chem Soc; 2015 Jan; 137(3):1230-44. PubMed ID: 25562380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UDP-galactopyranose mutase has a novel structure and mechanism.
    Sanders DA; Staines AG; McMahon SA; McNeil MR; Whitfield C; Naismith JH
    Nat Struct Biol; 2001 Oct; 8(10):858-63. PubMed ID: 11573090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimycobacterial activity of UDP-galactopyranose mutase inhibitors.
    Borrelli S; Zandberg WF; Mohan S; Ko M; Martinez-Gutierrez F; Partha SK; Sanders DA; Av-Gay Y; Pinto BM
    Int J Antimicrob Agents; 2010 Oct; 36(4):364-8. PubMed ID: 20678902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational Control of UDP-Galactopyranose Mutase Inhibition.
    Wangkanont K; Winton VJ; Forest KT; Kiessling LL
    Biochemistry; 2017 Aug; 56(30):3983-3992. PubMed ID: 28608671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic synthesis of UDP-galactofuranose and an assay for UDP-galactopyranose mutase based on high-performance liquid chromatography.
    Lee R; Monsey D; Weston A; Duncan K; Rithner C; McNeil M
    Anal Biochem; 1996 Nov; 242(1):1-7. PubMed ID: 8923956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of UDP-galactopyranose mutase thwart mycobacterial growth.
    Dykhuizen EC; May JF; Tongpenyai A; Kiessling LL
    J Am Chem Soc; 2008 May; 130(21):6706-7. PubMed ID: 18447352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A unique catalytic mechanism for UDP-galactopyranose mutase.
    Soltero-Higgin M; Carlson EE; Gruber TD; Kiessling LL
    Nat Struct Mol Biol; 2004 Jun; 11(6):539-43. PubMed ID: 15133501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.